Aminotropane derivatives, preparation thereof and...

Details Aminotropane derivatives, preparation thereof and... Aminotropane derivatives, preparation thereof and...

2007-01-25

2009-08-04

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S129000, C546S132000

Reexamination Certificate

active

07569582

ABSTRACT:
The present invention relates to compounds of formula (I) as defined herein that are melanocortin receptor agonists, to the preparation thereof and to the therapeutic use thereof in the treatment and in the prevention of obesity, diabetes and sexual dysfunctions that can affect both sexes, in the treatment of cardiovascular diseases, and also in anti-inflammatory uses or in the treatment of alcohol dependency.

REFERENCES:
patent: 5968929 (1999-10-01), Blythin et al.
patent: WO 02/059095 (2002-08-01), None
patent: WO 03/061660 (2003-07-01), None
Haqq et al., The Journal of clinical endocrinology and metabolism, (Jan. 2003) vol. 88, No. 1, pp. 174-178.
Holder, J.R., et. al., Melanocortin Ligands: 30 Years of Structure-Activity Relationship (SAR) Studies, Medicinal Research Reviews vol. 24, No. 3, pp. 325-356 (2004).
Irani, B.G., et. al., Progress in the Development of Melanocorting Receptor Selective Ligands, Current Pharmaceutical Design vol. 10, No. 28 (2004) pp. 3443-3479 (37).

Affiliated with

Also associated with

Rating

Aminotropane derivatives, preparation thereof and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminotropane derivatives, preparation thereof and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminotropane derivatives, preparation thereof and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4104511